The latest developments highlight CDMO deals, Q1 earnings, and AI medtech transformation as key drivers shaping the pharmaceutical sector
India’s healthcare sector saw major funding, partnerships, investments, expansion plans, and pharma developments this week. KKR moved to acquire Medicover India in a USD 1.5 billion healthcare deal. Cipla and Rocket India announced...
Clinical innovation drives a new wave of transformation as companies expand biosimilars portfolios, regulators strengthen drug quality frameworks
Skin cancer continues to challenge global healthcare systems as cases rise and treatment gaps persist. But a recent USFDA approval has introduced new hope in skin cancer treatment
The Semaglutide patent stands at the center of a major Novo Nordisk legal case as the company strengthens pharma patent enforcement across Europe
The latest developments highlight drug approvals, pharma investments, and healthcare innovation shaping the global and Indian pharmaceutical landscape
AI-powered manufacturing technology is transforming pharmaceutical production by enabling faster, smarter, and more precise manufacturing systems
Drug approvals and pharma manufacturing continue to shape the pharmaceutical landscape as new research, regulatory developments, and financial results drive industry momentum
Drug launches, pharma policy, and healthcare investment trends continue to reshape the global and Indian pharmaceutical landscape
Pharma regulations continue to shape global healthcare transformation as drug approvals and clinical trials drive safety, innovation, and market expansion